Here is a look at the scorecard of CareDx Inc. (NASDAQ:CDNA) for the most recent quarter as well as analyst estimates for the coming periods.
The company generated sales of 10.86M%, implying an increase of 0.39% compared to a similar quarter a year earlier.
To achieve the reported sales of 10.86M% for the quarter, the company incurred $6.48M in cost of goods. Therefore, after taking into account the cost of sales, CareDx Inc. emerged with a gross income of $4.38M.
Recently, CareDx, Inc (NASDAQ:CDNA) announced that, as expected, on May 22, 2017 it received a standard notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company did not timely file its Form 10-Q for the quarter ended March 31, 2017 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic reports with the Securities and Exchange Commission (the “SEC”).
Let?s look into the technical of the stock
The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction. Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.
CareDx Inc. also incurred other expenses in the course of operation. So after taking those into account as well, it exited the quarter with EPS of $(0.73). The company had 21.27M diluted outstanding shares at the end of the quarter.
For the next quarter, analysts on the average are modeling EPS of $-0.16.
CareDx Inc.’s cash balance at the end of the most recent quarter was 17.26M%. The company generated free cash flow of $(2.98M) during the quarter, with net operating cash flow being $(3.06M). Net change in cash was $(5.01M).
That said, CareDx Inc. finished the quarter with debt of 23.51M%. The debt increased/fell by growing from the past period.
What is Wall Street thinking about CareDx Inc.? So far 3 analysts have weighed on the stock, and from that it has average analyst recommendation of Overweight and average price target of $3.50. To put the analyst recommendation into perspective, recommendation in the range of 1.00 – 1.24 implies a BUY recommendation, while 1.25 – 1.74 implies OVERWEIGHT. HOLD recommendation is represented by 1.75 – 2.24, UNDERWEIGHT is represented by 2.25 – 2.74 while SELL is represented by 2.75 – 3.00.
Does CareDx Inc. have a healthy balance sheet? A look at the company’s balance sheet at the end of the most recent quarter shows that it reflects total assets of $79.67M, offset by total liabilities of $59.91M.